Aileron Therapeutics (ALRN) Short Interest Ratio & Short Volume → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free ALRN Stock Alerts $5.07 +0.14 (+2.84%) (As of 02:52 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Aileron Therapeutics Short Interest DataCurrent Short Volume43,400 sharesPrevious Short Volume35,300 sharesChange Vs. Previous Month+22.95%Dollar Volume Sold Short$257,362.00Short Interest Ratio / Days to Cover0.7Last Record DateApril 15, 2024Outstanding Shares16,970,000 sharesFloat Size13,890,000 sharesShort Percent of Float0.31%Today's Trading Volume50,046 sharesAverage Trading Volume64,388 sharesToday's Volume Vs. Average78% Short Selling Aileron Therapeutics ? Sign up to receive the latest short interest report for Aileron Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatALRN Short Interest Over TimeALRN Days to Cover Over TimeALRN Percentage of Float Shorted Over Time Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. Aileron Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202443,400 shares $257,362.00 +23.0%0.3%0.7 $5.93 3/31/202435,300 shares $234,039.00 +7.0%0.9%0.9 $6.63 3/15/202433,000 shares $184,140.00 -12.9%0.8%0.8 $5.58 2/29/202437,900 shares $187,226.00 +21.5%1.2%0.4 $4.94 2/15/202431,200 shares $146,016.00 -22.6%0.8%0.3 $4.68 1/31/202440,300 shares $178,126.00 -16.2%1.0%0.3 $4.42 Get the Latest News and Ratings for ALRN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aileron Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/202448,100 shares $189,514.00 +11.6%1.3%0.4 $3.94 12/31/202343,100 shares $131,394.66 -25.6%1.2%0.4 $3.05 12/15/202357,900 shares $220,020.00 -25.1%1.6%0.5 $3.80 11/30/202377,300 shares $163,876.00 +0.1%2.2%1.5 $2.12 11/15/202377,200 shares $118,888.00 +1,879.5%2.2%1.7 $1.54 10/31/20233,900 shares $4,563.00 -13.3%0.1%0.1 $1.17 10/15/20234,500 shares $5,629.95 -47.1%0.1%0.4 $1.25 9/30/20238,500 shares $12,920.00 -10.5%0.3%0.5 $1.52 9/15/20239,500 shares $15,295.00 +50.8%0.3%0.5 $1.61 8/31/20236,300 shares $10,395.00 +40.0%0.2%0.3 $1.65 8/15/20234,500 shares $7,425.00 +1,025.0%0.1%0.2 $1.65 7/31/2023400 shares $684.00 -96.4%0.0%0 $1.71 7/15/202311,100 shares $21,534.00 -8.3%0.3%0.5 $1.94 6/30/202312,100 shares $21,659.00 +1,916.7%0.4%0.5 $1.79 6/15/2023600 shares $1,104.00 -97.9%0.0%0 $1.84 5/31/202328,100 shares $41,588.00 +55.3%0.9%0.9 $1.48 5/15/202318,100 shares $26,426.00 -50.8%0.6%0.3 $1.46 4/30/202336,800 shares $53,455.68 +43.2%1.1%0.7 $1.45 4/15/202325,700 shares $42,405.00 -27.6%0.8%0.5 $1.65 3/31/202335,500 shares $44,020.00 -21.5%1.1%0.7 $1.24 3/15/202345,200 shares $66,444.00 +370.8%1.4%0.8 $1.47 2/28/20239,600 shares $14,304.00 -68.0%0.3%0.2 $1.49 2/15/202330,000 shares $76,200.00 +50.0%0.9%0.7 $2.54 1/31/202320,000 shares $55,600.00 +30.7%0.5%0.6 $2.78 1/15/202315,300 shares $46,447.74 -21.5%0.4%0.5 $3.04 12/30/202219,500 shares $46,215.00 -65.4%0.5%0.6 $2.37 12/15/202256,400 shares $147,768.00 +56.2%1.4%2.5 $2.62 11/30/202236,100 shares $99,997.00 +193.5%0.9%0.8 $2.77 11/15/202212,300 shares $41,328.00 -96.2%0.3%0.3 $3.36 10/31/2022322,000 shares $64,400.00 +24.4%0.5%0.4 $0.20 10/15/2022258,900 shares $52,815.60 -25.7%0.4%0.2 $0.20 9/30/2022348,500 shares $72,034.95 +450.6%0.5%0.3 $0.21 9/15/202263,300 shares $17,724.00 -25.8%0.1%0.1 $0.28 8/31/202285,300 shares $15,789.03 -82.6%0.1%0.1 $0.19World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. ALRN Short Interest - Frequently Asked Questions What is Aileron Therapeutics' current short interest? Short interest is the volume of Aileron Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 35,300 shares of ALRN short. 0.88% of Aileron Therapeutics' shares are currently sold short. Learn More on Aileron Therapeutics' current short interest. What is a good short interest ratio for Aileron Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALRN shares currently have a short interest ratio of 1.0. Learn More on Aileron Therapeutics's short interest ratio. What is a good short interest percentage for Aileron Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.88% of Aileron Therapeutics' floating shares are currently sold short. Is Aileron Therapeutics' short interest increasing or decreasing? Aileron Therapeutics saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 35,300 shares, an increase of 7.0% from the previous total of 33,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aileron Therapeutics' float size? Aileron Therapeutics currently has issued a total of 16,973,000 shares. Some of Aileron Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aileron Therapeutics currently has a public float of 4,000,000 shares. How does Aileron Therapeutics' short interest compare to its competitors? 0.88% of Aileron Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Aileron Therapeutics: InflaRx (0.66%), Oncolytics Biotech Inc. (1.23%), Affimed (1.51%), Leap Therapeutics, Inc. (4.87%), Marinus Pharmaceuticals, Inc. (6.32%), LifeVantage Co. (0.62%), Chimerix, Inc. (1.56%), Spero Therapeutics, Inc. (1.21%), Eton Pharmaceuticals, Inc. (0.98%), Connect Biopharma Holdings Limited (0.22%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Aileron Therapeutics stock? Short selling ALRN is an investing strategy that aims to generate trading profit from Aileron Therapeutics as its price is falling. ALRN shares are trading up $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aileron Therapeutics? A short squeeze for Aileron Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ALRN, which in turn drives the price of the stock up even further. How often is Aileron Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALRN, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: IFRX Short Interest Data ONCY Short Interest Data AFMD Short Interest Data LPTX Short Interest Data MRNS Short Interest Data LFVN Short Interest Data CMRX Short Interest Data SPRO Short Interest Data ETON Short Interest Data CNTB Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ALRN) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Goldtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research